Nurix Therapeutics, Inc. NRIX Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Nurix Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s free cash flow margin?
- Nurix Therapeutics, Inc. (NRIX) reported free cash flow margin of -378.7% in Q4 2025.
- How has Nurix Therapeutics, Inc.'s free cash flow margin changed year-over-year?
- Nurix Therapeutics, Inc.'s free cash flow margin decreased by 6.0% year-over-year, from -357.3% to -378.7%.
- What is the long-term trend for Nurix Therapeutics, Inc.'s free cash flow margin?
- Over 3 years (2021 to 2025), Nurix Therapeutics, Inc.'s free cash flow margin has grown at a 1.2% compound annual growth rate (CAGR), from -302.6% to -313.7%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.